Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin

NCT05593601 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT05593601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin
Lead sponsor
Mahidol University
Phase
Phase 4
Overall status
Unknown status
Start date
November 24, 2022
Completion date
March 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonization, asymptomatic